Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis
Public ClinicalTrials.gov record NCT03207815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects With Active Noninfectious Uveitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of filgotinib versus placebo for the treatment of the signs and symptoms of noninfectious uveitis as measured by the percentage of participants failing treatment for active noninfectious uveitis by Week 24.
Study identification
- NCT ID
- NCT03207815
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2017
- Primary completion
- Dec 28, 2020
- Completion
- Apr 21, 2021
- Last update posted
- Jan 20, 2022
2017 – 2021
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Byers Eye Institute | Palo Alto | California | 94303 | — |
| Colorado Retina Associates PC | Golden | Colorado | 80401 | — |
| Northwestern Medical Group | Chicago | Illinois | 60611 | — |
| Illinois Retina Associates | Oak Park | Illinois | 60304 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Associated Retinal Consultants PC | Royal Oak | Michigan | 48073 | — |
| Metropolitan Eye Research and Surgery Institute | Palisades Park | New Jersey | 07650 | — |
| Duke University Eye Center | Durham | North Carolina | 27710 | — |
| Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Cleveland Clinic Foundation-Cole Eye Institute | Cleveland | Ohio | 44191 | — |
| Oregon Health Science University-Casey Eye Institute | Portland | Oregon | 97239 | — |
| Mid Atlantic Retina | Philadelphia | Pennsylvania | 19107 | — |
| Texas Retina Associates - Fort Worth | Fort Worth | Texas | 76104 | — |
| Foresight Studies, LLC | San Antonio | Texas | 78240 | — |
| university of Wisconsin-Madison | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03207815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2022 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03207815 live on ClinicalTrials.gov.